id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-P-0188-0001,FDA,FDA-2007-P-0188,"Acknowledgement Letter from FDA DDM to Beckloff Associates, Inc.",Other,Acknowledgement Letter/Receipt,2007-12-28T05:00:00Z,2007,12,,,2015-05-07T18:08:20Z,,0,0,090000648042a763
FDA-2006-N-0364-0001,FDA,FDA-2006-N-0364,See FDA-2006-N-0364-0003,Supporting & Related Material,BKG-Background Material,2007-12-28T05:00:00Z,2007,12,,,2008-06-18T17:26:35Z,,0,0,090000648045fc49
FDA-2007-P-0178-0001,FDA,FDA-2007-P-0178,See FDA-2007-P-0178-0002,Supporting & Related Material,ACK-Acknowledgement Letter (Supporting and Related Material),2007-12-28T05:00:00Z,2007,12,,,2008-05-16T19:41:33Z,,0,0,090000648042a664
FDA-2007-D-0257-0001,FDA,FDA-2007-D-0257,See Document ID FDA-2007-D-0257-0003,Notice,,2007-12-28T00:00:00Z,2007,12,,,2008-05-21T20:22:03Z,,0,1,090000648042b1c1
FDA-2007-D-0257-0002,FDA,FDA-2007-D-0257,See Document ID FDA-2007-D-0257-0004,Other,,2007-12-28T00:00:00Z,2007,12,,,2008-05-21T20:21:19Z,,0,1,090000648042b1c4
FDA-2007-P-0414-0005,FDA,FDA-2007-P-0414,Minutes of Telecon Between FDA/CDER and Dr. Victor Yu and Cristina Chiou,Other,MT-Memorandum of Telephone Conversation,2007-12-27T05:00:00Z,2007,12,,,2008-04-04T00:38:15Z,,0,0,090000648042da1a
FDA-2007-N-0313-0001,FDA,FDA-2007-N-0313,Maximizing the Public Health Benefit of Adverse Event Collection Throughout a Product's Marketed Life Cycle; Public Workshop; Request for Comments,Notice,NM-Notice of Meeting,2007-12-26T05:00:00Z,2007,12,2007-12-21T05:00:00Z,2008-03-01T04:59:59Z,2008-08-15T01:38:12Z,,0,0,090000648042b70a
FDA-2007-N-0445-0003,FDA,FDA-2007-N-0445,Number not used,Other,,2007-12-26T05:00:00Z,2007,12,,,2025-08-14T22:07:10Z,,0,1,090000648042ddf6
FDA-2007-N-0197-0002,FDA,FDA-2007-N-0197,Agenda - Adolescent Over-the-Counter (OTC) Drug Product Use: A Public Workshop,Other,LST-List,2007-12-26T05:00:00Z,2007,12,,,2025-08-14T20:30:52Z,,0,0,090000648042a934
FDA-2007-N-0445-0002,FDA,FDA-2007-N-0445,Number Not Used,Other,,2007-12-26T05:00:00Z,2007,12,,,2025-08-14T22:05:39Z,,0,1,090000648042ddf5
FDA-2007-N-0445-0004,FDA,FDA-2007-N-0445,Number not used,Other,,2007-12-26T05:00:00Z,2007,12,,,2025-08-14T22:08:41Z,,0,1,090000648042ddf7
FDA-2007-N-0441-0001,FDA,FDA-2007-N-0441,"Agency Emergency Processing Under the Office of Management and Budget Review; Certification to Accompany Drug, Biological Product, and Device Applications or Submissions; Correction",Notice,Correction,2007-12-26T05:00:00Z,2007,12,,,2025-08-19T20:11:21Z,E7-24914,0,0,090000648042dda7
FDA-2007-C-0044-0001,FDA,FDA-2007-C-0044,"DSM Nutritional Products, Inc.; Filing of Color Additive Petition; Correction",Notice,NCR-Notice of Correction,2007-12-26T05:00:00Z,2007,12,2007-12-21T05:00:00Z,,2026-01-08T20:18:17Z,,0,0,0900006480429648
FDA-2007-N-0438-0002,FDA,FDA-2007-N-0438,Acknowledgment Letter from FDA DDM to Buchanan Ingersoll & Rooney PC,Other,Acknowledgement Letter/Receipt,2007-12-26T05:00:00Z,2007,12,,,2025-08-11T20:21:37Z,,0,0,090000648042dd74
FDA-2007-N-0152-0001,FDA,FDA-2007-N-0152,"Health Claims and Qualified Health Claims; Dietary Lipids and Cancer, Soy Protein and Coronary Heart Disease, Antioxidant Vitamins and Certain Cancers, and Selenium and Certain Cancers; Reevaluation; Opportunity for Public Comment",Notice,N-Notice,2007-12-21T05:00:00Z,2007,12,2007-12-21T05:00:00Z,2008-02-20T04:59:59Z,2008-07-08T18:53:47Z,,0,0,090000648042a409
FDA-2006-V-0402-0005,FDA,FDA-2006-V-0402,Lynne L. Rice,Other,VRA-Approval for Variance,2007-12-21T05:00:00Z,2007,12,,,2008-04-11T23:22:39Z,,0,0,0900006480460c6c
FDA-2007-P-0235-0001,FDA,FDA-2007-P-0235,"Acknowledgment Letter from FDA CDER to Mutual Pharmaceutical Company, Inc.",Other,Acknowledgement Letter/Receipt,2007-12-21T05:00:00Z,2007,12,,,2015-09-29T13:12:16Z,,0,0,090000648042b04d
FDA-2007-V-0252-0001,FDA,FDA-2007-V-0252,Acknowledgement Letter to KRJ Music Work,Other,ACK-Acknowledgement Letter,2007-12-21T05:00:00Z,2007,12,,,2008-04-09T14:15:14Z,,0,0,090000648042b160
FDA-2007-V-0356-0003,FDA,FDA-2007-V-0356,Lynne L. Rice - Approval for Variance,Other,VRA-Approval for Variance,2007-12-20T05:00:00Z,2007,12,,,2008-04-09T16:14:25Z,,0,0,090000648042ba0b
FDA-2007-A-0099-0002,FDA,FDA-2007-A-0099,Letter from FDA CDER Interim Response to AstraZeneca Ropes and Gray LLP,Other,Letter(s),2007-12-20T05:00:00Z,2007,12,,,2014-01-21T00:25:14Z,,0,0,0900006480429d7a
FDA-2007-V-0426-0002,FDA,FDA-2007-V-0426,Lynne L. Rice - Approval for Variance,Other,VRA-Approval for Variance,2007-12-20T05:00:00Z,2007,12,,,2008-04-09T18:31:27Z,,0,0,090000648042dbe4
FDA-2007-P-0243-0001,FDA,FDA-2007-P-0243,Acknowledgement Letter to Michael J. Dochniak,Other,ACK-Acknowledgement Letter,2007-12-20T05:00:00Z,2007,12,,,2008-07-22T22:56:16Z,,0,0,090000648042b0be
FDA-2007-N-0083-0020,FDA,FDA-2007-N-0083,"Behind the Counter Availability of Certain Drugs; Public Meeting Wednesday, November 14, 2007 - Transcript",Supporting & Related Material,TR-Transcript,2007-12-19T05:00:00Z,2007,12,,,2008-05-12T06:10:30Z,,0,0,0900006480429b07
FDA-2007-M-0452-0001,FDA,FDA-2007-M-0452,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-09T22:48:41Z,E7-24620,0,0,090000648042dec7
FDA-2007-N-0083-0021,FDA,FDA-2007-N-0083,"Behind the Counter Availability of Certain Drugs; Press Briefing on Public Meeting Wednesday, November 14, 2007 - Transcript",Supporting & Related Material,TR-Transcript,2007-12-19T05:00:00Z,2007,12,,,2008-05-12T06:12:01Z,,0,0,0900006480429b08
FDA-2007-M-0273-0001,FDA,FDA-2007-M-0273,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-09T21:15:57Z,E7-24620,0,0,090000648042b3c6
FDA-2007-M-0453-0001,FDA,FDA-2007-M-0453,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-10T00:23:52Z,E7-24620,0,0,090000648042ded7
FDA-2007-M-0325-0001,FDA,FDA-2007-M-0325,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-10T04:01:42Z,E7-24620,0,0,090000648042b804
FDA-2007-N-0382-0001,FDA,FDA-2007-N-0382,"Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting",Notice,Meeting,2007-12-19T05:00:00Z,2007,12,,,2025-08-19T15:55:54Z,E7-24629,0,0,090000648042d70f
FDA-2007-M-0397-0001,FDA,FDA-2007-M-0397,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-12T23:22:10Z,E7-24620,0,0,090000648042d84e
FDA-2007-M-0224-0001,FDA,FDA-2007-M-0224,FDA,Notice,NAL-Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2008-04-04T00:35:16Z,,0,0,090000648042ae2e
FDA-2007-M-0223-0001,FDA,FDA-2007-M-0223,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-09T23:33:10Z,E7-24620,0,0,090000648042ae1d
FDA-2007-M-0093-0001,FDA,FDA-2007-M-0093,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-13T00:37:18Z,E7-24620,0,0,0900006480429d20
FDA-2005-D-0013-0007,FDA,FDA-2005-D-0013,Collection of Platelets by Automated Methods,Supporting & Related Material,Guidance,2007-12-18T05:00:00Z,2007,12,,,2020-05-14T14:55:21Z,,0,0,090000648043e53e
FDA-2007-D-0306-0002,FDA,FDA-2007-D-0306,International Conference on Harmonisation; Draft Guidance on Q4B,Notice,NAD-Notice of Availability of Data,2007-12-18T05:00:00Z,2007,12,2007-12-14T05:00:00Z,2008-02-16T04:59:59Z,2009-01-12T16:01:41Z,,0,0,090000648042b66c
FDA-2007-D-0200-0002,FDA,FDA-2007-D-0200,International Conference on Harmonisation; Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions; Annex on Test for Extractable Volume of Parenteral Preparations General Chapter; Availibilty,Notice,NAD-Notice of Availability of Data,2007-12-18T05:00:00Z,2007,12,2007-12-14T05:00:00Z,2008-02-16T04:59:59Z,2008-05-28T19:58:35Z,,0,0,090000648042abc7
FDA-2007-D-0306-0001,FDA,FDA-2007-D-0306,"4QB Evaluation and Recommendation of Pharmacopeial Texts for Use in the ICH Regions, Annex 3 - Guidance - Draft Guidance",Supporting & Related Material,GDL-Guidance,2007-12-18T05:00:00Z,2007,12,,,2009-01-12T16:04:33Z,,0,0,090000648042b66d
FDA-2007-D-0200-0001,FDA,FDA-2007-D-0200,See FDA-2007-D-0200-0003,Supporting & Related Material,GDL-Guidance,2007-12-18T05:00:00Z,2007,12,,,2010-04-07T15:41:46Z,,0,0,090000648042abc9
FDA-2005-D-0013-0008,FDA,FDA-2005-D-0013,FDA,Notice,NAD-Notice of Availability of Data,2007-12-18T05:00:00Z,2007,12,2007-12-14T05:00:00Z,2008-12-16T04:59:59Z,2008-04-11T23:46:16Z,,0,0,090000648043e53f
FDA-2007-P-0184-0001,FDA,FDA-2007-P-0184,Acknowledgement Letter to Judy Slome Cohain,Other,ACK-Acknowledgement Letter,2007-12-18T05:00:00Z,2007,12,,,2008-07-07T17:57:57Z,,0,0,090000648042a728
FDA-2007-P-0110-0001,FDA,FDA-2007-P-0110,FDA/DDM to Physicians Committee for Responsible Medicine (PCRM),Other,ACK-Acknowledgement Letter,2007-12-18T05:00:00Z,2007,12,,,2008-04-04T00:37:11Z,,0,0,0900006480429e5f
FDA-2006-P-0275-0006,FDA,FDA-2006-P-0275,Citizen Petition Denial from FDA CDER to KV Pharmaceutical Co,Other,Denial of Petition,2007-12-17T05:00:00Z,2007,12,,,2024-12-05T14:53:49Z,,0,0,090000648045829b
FDA-2007-P-0417-0001,FDA,FDA-2007-P-0417,Acknowledgement Letter to Consumers Union,Other,ACK-Acknowledgement Letter,2007-12-17T05:00:00Z,2007,12,,,2013-05-15T19:58:29Z,,0,0,090000648042da4d
FDA-2007-N-0319-0001,FDA,FDA-2007-N-0319,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Health and Diet Survey,Notice,30 Day Proposed Information Collection,2007-12-17T05:00:00Z,2007,12,2007-12-13T05:00:00Z,2008-01-15T04:59:59Z,2025-07-18T17:30:47Z,E7-24123,0,0,090000648042b7c7
FDA-2007-P-0122-0052,FDA,FDA-2007-P-0122,FDA/CFSAN Interim Response to Compassion Over Killing & Penn Law Animal Law Project-University of Pennsylvania Law School - Letter,Other,LET-Letter,2007-12-17T05:00:00Z,2007,12,,,2008-11-26T05:47:43Z,,0,0,090000648042a1cf
FDA-2005-P-0253-0019,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442e7
FDA-2005-P-0253-0006,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442da
FDA-2005-P-0253-0005,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442d9
FDA-2005-P-0253-0013,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442e1
FDA-2005-P-0253-0012,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442e0
FDA-2005-P-0253-0021,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442e9
FDA-2005-P-0253-0008,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442dc
FDA-2005-P-0253-0016,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442e4
FDA-2005-P-0253-0009,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:03Z,,0,0,09000064804442dd
FDA-2005-P-0253-0010,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442de
FDA-2005-P-0253-0017,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442e5
FDA-2005-P-0253-0014,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442e2
FDA-2005-P-0253-0015,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442e3
FDA-2005-P-0253-0018,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442e6
FDA-2005-P-0253-0020,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442e8
FDA-2005-P-0253-0011,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:03Z,,0,0,09000064804442df
FDA-2005-P-0253-0007,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442db
FDA-2005-P-0253-0022,FDA,FDA-2005-P-0253,"J. Shuren, Assistant Commissioner for Policy",Other,PDN-Petition Denial,2007-12-13T05:00:00Z,2007,12,,,2008-04-12T00:09:02Z,,0,0,09000064804442ea
FDA-2007-V-0421-0001,FDA,FDA-2007-V-0421,Acknowledgement Letter to X- Laser L. L. C.,Other,ACK-Acknowledgement Letter,2007-12-12T05:00:00Z,2007,12,,,2008-04-09T18:12:29Z,,0,0,090000648042daca
FDA-2007-V-0253-0001,FDA,FDA-2007-V-0253,"Acknowledgement Letter to X- Laser, L. L. C.",Other,ACK-Acknowledgement Letter,2007-12-12T05:00:00Z,2007,12,,,2008-04-09T14:30:16Z,,0,0,090000648042b16e
FDA-2007-N-0441-0002,FDA,FDA-2007-N-0441,"Agency Emergency Processing Under the Office of Management and Budget Review; Certification to Accompany Drug, Biological Product, and Device Applications or Submissions",Notice,General Notice,2007-12-12T05:00:00Z,2007,12,2007-12-12T05:00:00Z,2007-12-18T04:59:59Z,2025-08-19T20:24:09Z,07-6023,0,0,090000648042dda4
FDA-2007-N-0272-0002,FDA,FDA-2007-N-0272,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Presubmission Conferences, New Animal Drug Applications and Supporting Regulations and Guidance 152, and Form FDA 356V",Notice,30 Day Proposed Information Collection,2007-12-11T05:00:00Z,2007,12,2007-12-11T05:00:00Z,2008-01-11T04:59:59Z,2025-07-23T19:31:13Z,E7-23998,0,0,090000648042b3bd
FDA-2007-N-0220-0002,FDA,FDA-2007-N-0220,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Pharmacogenomic Data Submissions; Extension,Notice,30 Day Proposed Information Collection,2007-12-11T05:00:00Z,2007,12,2007-12-11T05:00:00Z,2008-01-11T04:59:59Z,2025-08-07T22:57:55Z,E7-23996,0,0,090000648042adfb
FDA-2007-N-0383-0003,FDA,FDA-2007-N-0383,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Radioactive Drug Research Committees,Notice,30 Day Proposed Information Collection,2007-12-11T05:00:00Z,2007,12,2007-12-10T05:00:00Z,2008-01-11T04:59:59Z,2025-08-11T16:06:25Z,E7-23977,0,0,090000648042d750
FDA-2000-P-0152-0011,FDA,FDA-2000-P-0152,Background Material,Supporting & Related Material,BKG-Background Material,2007-12-11T05:00:00Z,2007,12,,,2008-04-25T01:44:23Z,,0,0,09000064804d1372
FDA-2007-C-0044-0002,FDA,FDA-2007-C-0044,"DSM Nutritional Products, Inc.; Filing of Color Additive Petition",Notice,NFL-Notice of Filing,2007-12-11T05:00:00Z,2007,12,2007-12-03T05:00:00Z,,2026-01-08T20:19:27Z,,0,0,0900006480429647
FDA-2000-P-0152-0015,FDA,FDA-2000-P-0152,Background Material,Supporting & Related Material,BKG-Background Material,2007-12-11T05:00:00Z,2007,12,,,2008-04-25T01:44:24Z,,0,0,09000064804d1378
FDA-2007-P-0288-0002,FDA,FDA-2007-P-0288,FDA/CDRH to Clinical and Laboratory Standards Institute,Other,LET-Letter,2007-12-11T05:00:00Z,2007,12,,,2008-04-04T00:37:52Z,,0,0,090000648042b4f1
FDA-2007-P-0187-0001,FDA,FDA-2007-P-0187,FDA/DDM to Alston & Bird LLP,Other,ACK-Acknowledgement Letter,2007-12-11T05:00:00Z,2007,12,,,2008-04-04T00:37:35Z,,0,0,090000648042a754
FDA-2007-N-0080-0001,FDA,FDA-2007-N-0080,Establishment of Fiscal Year 2008 User Fee Rates for Advisory Review of Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products,Notice,General Notice,2007-12-11T05:00:00Z,2007,12,,,2025-08-19T00:31:05Z,E7-24000,0,0,09000064804298e2
FDA-2007-P-0115-0002,FDA,FDA-2007-P-0115,CDRH to Clinical and Laboratory Standards Institute,Other,LET-Letter,2007-12-11T05:00:00Z,2007,12,,,2008-04-04T00:37:13Z,,0,0,0900006480429ef7
FDA-2000-P-0152-0014,FDA,FDA-2000-P-0152,Background Material,Supporting & Related Material,BKG-Background Material,2007-12-11T05:00:00Z,2007,12,,,2008-04-25T01:44:21Z,,0,0,09000064804d1376
FDA-2000-P-0152-0013,FDA,FDA-2000-P-0152,Background Material,Supporting & Related Material,BKG-Background Material,2007-12-11T05:00:00Z,2007,12,,,2008-04-25T01:44:18Z,,0,0,09000064804d1375
FDA-2007-P-0187-0002,FDA,FDA-2007-P-0187,FDA/DDM to Alston & Bird LLP,Other,ACK-Acknowledgement Letter,2007-12-11T05:00:00Z,2007,12,,,2008-04-04T00:37:35Z,,0,0,090000648042a759
FDA-2007-N-0266-0001,FDA,FDA-2007-N-0266,Agency Information Collection Activities; Proposed Collection; Comment Request; Reports of Corrections and Removals,Notice,N-Notice,2007-12-11T05:00:00Z,2007,12,2007-12-11T05:00:00Z,2008-02-12T04:59:59Z,2025-08-18T23:08:07Z,E7-23962,0,0,090000648042b37a
FDA-2000-P-0152-0010,FDA,FDA-2000-P-0152,FDA,Notice,NEC-Notice of Extension,2007-12-11T05:00:00Z,2007,12,2007-12-10T05:00:00Z,2008-02-12T04:59:59Z,2008-04-25T01:44:24Z,,0,0,09000064804d1371
FDA-2000-P-0152-0012,FDA,FDA-2000-P-0152,Background Material,Supporting & Related Material,BKG-Background Material,2007-12-11T05:00:00Z,2007,12,,,2008-04-25T01:44:21Z,,0,0,09000064804d1373
FDA-2007-0629-0001,FDA,FDA-2007-0629,Cheeses and Related Cheese Products; Proposal to Permit the Use of Ultrafiltered Milk; Reopening of the Comment Period,Proposed Rule,NPR-Notice of Proposed Rule-Making,2007-12-11T05:00:00Z,2007,12,2007-12-11T05:00:00Z,2008-02-12T04:59:59Z,2008-02-11T12:07:54Z,E7-23981,0,0,09000064803779cd
FDA-2000-P-0152-0016,FDA,FDA-2000-P-0152,Background Material,Supporting & Related Material,BKG-Background Material,2007-12-11T05:00:00Z,2007,12,,,2008-04-25T01:44:23Z,,0,0,09000064804d137b
FDA-2007-N-0087-0001,FDA,FDA-2007-N-0087,Agency Information Collection Activities; Proposed Collection; Comment Request; Mental Models Study of Communicating With Health Care Providers About the Risks and Benefits of Prescription Drug Use for Pregnant and Nursing Women With Chronic Conditions,Notice,60 Day Proposed Information Collection,2007-12-11T05:00:00Z,2007,12,2007-12-10T05:00:00Z,2008-02-12T04:59:59Z,2025-09-24T22:10:20Z,E7-23976,0,0,0900006480429c98
FDA-1978-N-0018-0629,FDA,FDA-1978-N-0018,"Envelope re: Comment from The Honorable Benjamin J. Lambert III, Senate of Virginia",Supporting & Related Material,Transmittals,2007-12-07T05:00:00Z,2007,12,,,2019-07-29T15:44:10Z,,0,0,090000648055c0f1
FDA-1978-N-0018-0628,FDA,FDA-1978-N-0018,"Envelope re: Comment from The Honorable Benjamin J. Lambert III, Senate of Virginia",Supporting & Related Material,Transmittals,2007-12-07T05:00:00Z,2007,12,,,2019-07-29T15:47:20Z,,0,0,090000648055c0ee
FDA-2007-P-0066-0001,FDA,FDA-2007-P-0066,FDA/ DDM to William L. Driscoll,Other,ACK-Acknowledgement Letter,2007-12-07T05:00:00Z,2007,12,,,2008-04-04T00:37:08Z,,0,0,09000064804297f2
FDA-2007-E-0281-0005,FDA,FDA-2007-E-0281,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2007-12-06T05:00:00Z,2007,12,,,2026-01-06T23:23:28Z,,0,0,090000648042b44b
FDA-2007-P-0245-0003,FDA,FDA-2007-P-0245,FDA/CDER Interim Response to Perdue Pharma L.P. - Letter,Other,LET-Letter,2007-12-06T05:00:00Z,2007,12,,,2009-03-28T18:18:01Z,,0,0,090000648042b0f0
FDA-2006-N-0239-0007,FDA,FDA-2006-N-0239,Index of Legally Marketed Unapproved New Animal Drugs for Minor Species; Final Rule,Notice,Notice of Final Rule,2007-12-06T05:00:00Z,2007,12,2007-12-05T05:00:00Z,,2015-12-15T17:50:54Z,,0,0,0900006480456f42
FDA-1978-N-0018-0626,FDA,FDA-1978-N-0018,Envelope re: Comment from Harry R. (Bob) Purkey,Supporting & Related Material,Transmittals,2007-12-05T05:00:00Z,2007,12,,,2019-07-29T15:24:09Z,,0,0,090000648055c0e4
FDA-2007-E-0106-0007,FDA,FDA-2007-E-0106,USPTO to Intervet Inc. - Letter,Other,LET-Letter,2007-12-05T05:00:00Z,2007,12,,,2008-05-02T15:45:09Z,,0,0,0900006480429e1e
FDA-2007-P-0234-0001,FDA,FDA-2007-P-0234,"Acknowledgement Letter to Terence J. Mix, Esq.",Other,ACK-Acknowledgement Letter,2007-12-04T05:00:00Z,2007,12,,,2012-09-22T20:26:02Z,,0,0,090000648042b03f
FDA-2007-0614-0001,FDA,FDA-2007-0614,Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Companion Document to the Direct Final Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2007-12-04T05:00:00Z,2007,12,2007-12-04T05:00:00Z,2008-02-20T04:59:59Z,2015-12-07T15:03:20Z,E7-23292,0,0,090000648036fb2c
FDA-2007-F-0330-0001,FDA,FDA-2007-F-0330,"General Mills, Inc.; Filing of Food Additive Petition (FAP 7M4770)",Notice,NFL-Notice of Filing,2007-12-04T05:00:00Z,2007,12,2007-11-30T05:00:00Z,,2026-01-08T19:37:41Z,,0,0,090000648042b848
FDA-2007-N-0074-0001,FDA,FDA-2007-N-0074,Number not used,Notice,NFL-Notice of Filing,2007-12-04T05:00:00Z,2007,12,2007-12-03T05:00:00Z,,2008-04-04T00:35:37Z,,0,0,090000648042988b
FDA-2007-N-0379-0002,FDA,FDA-2007-N-0379,Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals,Rule,Direct Final Rule,2007-12-04T05:00:00Z,2007,12,2007-12-04T05:00:00Z,2008-02-20T04:59:59Z,2025-07-28T22:38:38Z,E7-23294,0,0,090000648042c911
FDA-2007-N-0379-0001,FDA,FDA-2007-N-0379,Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Companion Document to the Direct Final Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2007-12-04T05:00:00Z,2007,12,2007-12-04T05:00:00Z,2008-02-20T04:59:59Z,2025-07-29T09:00:10Z,E7-23292,0,0,090000648042c910
FDA-2007-P-0182-0002,FDA,FDA-2007-P-0182,FDA Center for Drug and Evaluation Research Response to Sanofi Aventis - Letter,Other,LET-Letter,2007-12-04T05:00:00Z,2007,12,,,2008-07-15T23:43:46Z,,0,0,090000648042a706